Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa

Shabir A. Madhi, Vicky Baillie, Clare L. Cutland, Merryn Voysey, Anthonet L. Koen, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim Ebrahim Bhorat, Carmen Briner, Gaurav Kwatra, NGS-SA, Wits-VIDA COVID team, Khatija Ahmed, Parvinder Aley, Sutika Bhikha, Jinal N. Bhiman, As’ad Ebrahim Bhorat, Jeanine du Plessis, Aliasgar Esmail, Marisa Groenewald, Elizea Horne, Shi-Hsia Hwa, Aylin Jose, Teresa Lambe, Matt Laubscher, Mookho Malahleha, Masebole Masenya, Mduduzi Masilela, Shakeel McKenzie, Kgaogelo Molapo, Andrew Moultrie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Lindie Rossouw, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Samuel van Eck, Constantinos Kurt Wibmer, Nicholas M. Durham, Elizabeth J Kelly, Tonya L Villafana, Sarah Gilbert, Andrew J Pollard, Tulio de Oliveira, Penny L. Moore, Alex Sigal, Alane Izu
doi: https://doi.org/10.1101/2021.02.10.21251247

Article Information

doi 
https://doi.org/10.1101/2021.02.10.21251247
History 
  • February 12, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Shabir A. Madhi, PhD1,2,†,
  2. Vicky Baillie, PhD1,2,#,
  3. Clare L. Cutland, PhD3,#,
  4. Merryn Voysey, DPhil4,
  5. Anthonet L. Koen, MBBCh1,2,*,
  6. Lee Fairlie, FCPaeds5,*,
  7. Sherman D. Padayachee, MBChB6,*,
  8. Keertan Dheda, PhD7,*,
  9. Shaun L. Barnabas, PhD8,*,
  10. Qasim Ebrahim Bhorat, MSc9,*,
  11. Carmen Briner, MBBCh10,*,
  12. Gaurav Kwatra, PhD1,2,
  13. NGS-SA11,
  14. Wits-VIDA COVID team12,
  15. Khatija Ahmed, FCPath (Micro)6,
  16. Parvinder Aley, DPhil4,
  17. Sutika Bhikha, MBBCh1,2,
  18. Jinal N. Bhiman, PhD15,16,
  19. As’ad Ebrahim Bhorat, FRACGP9,
  20. Jeanine du Plessis1,
  21. Aliasgar Esmail, MD7,
  22. Marisa Groenewald, MBBCH8,
  23. Elizea Horne, MBBCH5,
  24. Shi-Hsia Hwa, MSc17,19,
  25. Aylin Jose1,
  26. Teresa Lambe, PhD14,
  27. Matt Laubscher, MSc1,
  28. Mookho Malahleha, MBChB6,
  29. Masebole Masenya, MBChB5,
  30. Mduduzi Masilela, MBChB6,
  31. Shakeel McKenzie, BSc1,
  32. Kgaogelo Molapo6,
  33. Andrew Moultrie, BSc Hons1,
  34. Suzette Oelofse, MBChB7,
  35. Faeezah Patel, MBBCh5,
  36. Sureshnee Pillay20,
  37. Sarah Rhead, MBChB4,
  38. Hylton Rodel, BSc17,19,
  39. Lindie Rossouw, MBBCH8,
  40. Carol Taoushanis, BPharm1,
  41. Houriiyah Tegally20,
  42. Asha Thombrayil, MBBCh1,
  43. Samuel van Eck, RN5,
  44. Constantinos Kurt Wibmer, PhD15,16,
  45. Nicholas M. Durham13,
  46. Elizabeth J Kelly13,
  47. Tonya L Villafana, PhD13,
  48. Sarah Gilbert, PhD14,#,
  49. Andrew J Pollard, FMedSci4,#,
  50. Tulio de Oliveira, PhD20,#,
  51. Penny L. Moore, PhD15,16,#,
  52. Alex Sigal, PhD17,18,# and
  53. Alane Izu, PhD1,2,#
  1. ↵†Corresponding author: Shabir A. Madhi shabir.madhi@wits{at}ac.za Cell +27(82)8706672
    1. 1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    2. 2Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
    3. 3African Leadership in Vaccinology Expertise, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    4. 4Oxford Vaccine Group, Department of Paediatrics, University of Oxford, UK
    5. 5Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    6. 6Setshaba Research Centre, Tshwane, South Africa
    7. 7Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, South Africa Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK
    8. 8Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa
    9. 9Soweto Clinical Trials Centre, Soweto, South Africa
    10. 10Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    11. 11Network for Genomic Surveillance in South Africa (NGS-SA) group
    12. 12Wits VIDA COVID vaccine trial group
    13. 13Astra Zeneca Biopharmaceuticals, Cambridge, UK
    14. 14Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK
    15. 15National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
    16. 16Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    17. 17Africa Health Research Institute, Durban, South Africa
    18. 18Max Planck Institute for Infection Biology, Berlin, Germany
    19. 19Division of Infection and Immunity, University College London, London, UK
    20. 20KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban South Africa

    1. ↵# Equal contribution

    2. ↵* Equal contribution

    Back to top
    Posted February 12, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email
    Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa
    Shabir A. Madhi, Vicky Baillie, Clare L. Cutland, Merryn Voysey, Anthonet L. Koen, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim Ebrahim Bhorat, Carmen Briner, Gaurav Kwatra, NGS-SA, Wits-VIDA COVID team, Khatija Ahmed, Parvinder Aley, Sutika Bhikha, Jinal N. Bhiman, As’ad Ebrahim Bhorat, Jeanine du Plessis, Aliasgar Esmail, Marisa Groenewald, Elizea Horne, Shi-Hsia Hwa, Aylin Jose, Teresa Lambe, Matt Laubscher, Mookho Malahleha, Masebole Masenya, Mduduzi Masilela, Shakeel McKenzie, Kgaogelo Molapo, Andrew Moultrie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Lindie Rossouw, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Samuel van Eck, Constantinos Kurt Wibmer, Nicholas M. Durham, Elizabeth J Kelly, Tonya L Villafana, Sarah Gilbert, Andrew J Pollard, Tulio de Oliveira, Penny L. Moore, Alex Sigal, Alane Izu
    medRxiv 2021.02.10.21251247; doi: https://doi.org/10.1101/2021.02.10.21251247
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools

    Subject Area